ACA
Overvalued by 1.7% based on the discounted cash flow analysis.
Market cap | $3.77 Billion |
---|---|
Enterprise Value | $4.23 Billion |
Dividend Yield | $0.1998 (0.26%) |
Earnings per Share | $3.27 |
Beta | 1.06 |
Outstanding Shares | 48,561,836 |
Avg 30 Day Volume | 265,943 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 23.67 |
---|---|
PEG | -28.83 |
Price to Sales | 1.88 |
Price to Book Ratio | 1.84 |
Enterprise Value to Revenue | 1.83 |
Enterprise Value to EBIT | 23.17 |
Enterprise Value to Net Income | 26 |
Total Debt to Enterprise | 0.13 |
Debt to Equity | 0.24 |
No data
No data